Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy
Notice
Health and Human Services Department, National Institutes of Health
Notice
July 2, 2026
2026-13480
📄 Summary
The National Cancer Institute (NCI) seeks research co- development partners and/or licensees for viral peptide (CE1)-based therapeutics for HCC prevention and treatment.
